Figure 1 - LIS Technologies Inc. Engages Dr. Lukasz Urbanski as the Director of its Stable Isotope Laser Program. Prior to the architect role at ASML, Dr. Urbanski served as a Staff Systems ...

Laser isotope separation specialist is working on 5.3 µm sources for uranium enrichment. LIS Technologies (LIST), the US startup working on a novel laser-based approach to uranium enrichment, says it ...

We predicted that screens on everything was likely to be something of a trend at Computex this year. So, an AIO cooler with a screen on the water block isn't exactly radical. So, to give it an ...

With total assets of $53.7 billion, FWD Group has launched its fourth IPO attempt in Hong Kong, tapping into surging investor interest following battery giant CATL’s landmark listing. Hong Kong ...

FWD Group Holdings, the insurer backed by tycoon Richard Li Tzar-kai, filed for a share offering in Hong Kong just a day ahead of the trading debut of the world’s largest new listing this year ...

A total of 14 million Medicare beneficiaries receive the Low-Income Subsidy (LIS), which reduces cost sharing in Medicare Part D. Losing the LIS may impede medication access and affect mortality.

Folding together electronics, woodwind, and brass, the Canadian composer’s first solo album in eight years is her most peaceful yet; it seems to float in a state of comfortable daze. For the ...

Trent Reznor & Boy George), Preoccupations, TVOD, Das Koolies (mem Super Furry Animals), King Hüsky (mem Kvelertak), Le Volume Courbe (ft. Noel Gallagher, Terry Hall & Primal Scream’s Martin ...

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...

As the most discerning, up-to-the-minute voice in all things travel, Condé Nast Traveler is the global citizen’s bible and muse, offering both inspiration and vital intel. We understand that ...

However, the court ruled that his claim has no evidence, suggesting that neither Messier nor his family currently use the fleur-de-lis in any commercial capacity to merit consideration.